依托考昔类|Etoricoxib-毕得医药

搜索购物车会员中心

依托考昔能选择性抑制COX-2，IC50为1.1μM（LPS诱导的前列腺素E2合成实验），而对COX-1的IC50则为116μM（凝血后血清血栓素B2生成实验）。

默认常备现货
纯度
- 请选择
- 99+%
- 99%
- 98+%
- 98%
- 97+%
- 97%
- 96+%
- 96%
- 95+%
- 95%
- 93%
- 90+%
- 90%
规格
- 请选择
- 1mg
- 2mg
- 5mg
- 10mg
- 25mg
- 50mg
- 100mg
- 250mg
- 1g
- 5g
- 10g
- 25g
- 100g
- 500g
- 1000g
- 1kg

清空选项

(Z)-N-[2-Chloro-3-(dimethylamino)allylidene]-N-methylmethanaminium Hexafluorophosphate: BD271831291756-76-898%; ￥43.0025g常备现货

1-(6-Methylpyridin-3-yl)-2-(4-(methylthio)phenyl)ethanone: BD449988221615-72-197%; ￥532.001g常备现货

1-(6-Methylpyridin-3-yl)-2-(4-(methylsulfonyl)phenyl)ethanone: BD41468221615-75-497%; ￥55.005g常备现货

4-(Methylsulfonyl)benzaldehyde: BD64075398-77-697%; ￥66.00100g常备现货

N-Methoxy-N,6-dimethylnicotinamide: BD297103221615-71-095+%; ￥2996.001g

1